Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPATASERTIB vs IRINOTECAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPATASERTIB vs IRINOTECAN: Safety Overview

Metric IPATASERTIB IRINOTECAN
Total FAERS Reports 125 27,965
Deaths Reported 20 4,530
Death Rate 16.0% 16.2%
Hospitalizations 95 10,384
Average Patient Age 61.7 yrs 58.7 yrs
% Female Patients 57.0% 41.4%
FDA Approval Date N/A Apr 11, 2022
Manufacturer N/A Armas Pharmaceuticals Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription